
The Asia-Pacific Oncology Drug Development Consortium (APODDC) is hosting its 2nd Virtual Molecular Tumour Board (vMTB). This complimentary, specialized webinar is scheduled for Wednesday, November 26, 2025, running from 4:00 PM to 5:15 PM (GMT+8). The session is highly relevant for professionals across the region interested in cutting-edge oncology practices.
The second session of the vMTB will be hosted by executive member Prof. Toshio Shimizu, and will feature expert insights from Dr. Tahlia Scheinberg and A/Prof. Ben Tran. The speakers will concentrate on practical profiling strategies and treatment planning used within the field of genitourinary cancers, specifically using detailed bladder and prostate cancer case studies to illustrate their points.